Together, we can do better.
Today's Reality:
average time physicians spend discussing
newly prescribed medications with patients
With Medication Therapy Optimization (MTO):
reduction in emergency room visits
reduction of inpatient days
Source: Jarvis, JP, et al. Real-World Impact of a Pharmacogenomics-Enriched
Comprehensive Medication Management Program. Journal of Personalized Medicine, 2022
Medication Therapy Management (MTM)
Drives “adherence”
- to standardized clinical pathways
- to reimbursement protocols
- to formulary guidelines
- to “typical” medication regimens
VS
Medication Therapy Optimization (MTO)
Drives efficacy & safety
- for individual patients
- informed by the most current medical & data science
The DecisionRx MTO Platform
Our specialized clinical pharmacists act as unbiased patient advocates to optimize each member’s medication therapy for efficacy, safety, adherence, and total healthcare cost.
The DecisionRx MTO platform incorporates:
- Proprietary medication risk stratification
- Clinical history and medical claims analysis
- Pharmacogenomics testing
- Comprehensive medication review by specialized clinical pharmacists
- Coordination with prescribers’ existing workflows
- A value-based economic model: DecisionRx bears the full cost of MTO implementation
The MTO process enables physicians to optimize and tailor medication plans for each patient, improving outcomes and reducing healthcare costs. The platform focuses on buying the right drugs, rather than merely buying drugs at the right price.
The DecisionRx platform assigns medication failure risk scores to each patient using the most current clinical data regarding drug interactions, contraindications, side effects, adverse events, FDA warnings, and pharmacogenomics. These risk scores prioritize patients most likely to benefit from comprehensive pharmacist reviews, dramatically reducing the clinical and economic costs of non-optimized medication therapy.
Estimate the Impact of MTO on Your Health Plan
Your Health Plan
Health Plan Type
[Plan Type]
Number of Covered Lives
35,000
MTO Impact
3,710
3,710
3,710
Annual medical cost reduction
000,000,000
✱
Estimates based on aggregated DecisionRx patient data, and assume risk-targeted MTO assessments are completed for 20% of the population. For a detailed analysis specific to your plan members, contact [email protected].
Copyright 2024. All Rights Reserved | DecisionRx, Inc. | 8 The Green, Suite A, Dover DE, 19901 | 800-957-3606 | Contact Us